Posts by: Alice Melão

News

Sexuality and intimacy are important aspects of one’s life that are also affected by amyotrophic lateral sclerosis (ALS), according to a review study. It is important that clinicians and ... Read more

December 7, 2018December 7, 2018

Biogen Acquires Full Rights to Develop, Market BIIB067 as Potential Treatment for ALS

News

Biogen has decided to exercise its option to acquire from Ionis Pharmaceuticals the exclusive rights to develop and commercialize BIIB067 as a potential treatment for amyotrophic lateral sclerosis (ALS). The decision ... Read more

December 4, 2018December 4, 2018

Fruit Compound Called Resveratrol May Strengthen Abilities of Stems Cells of ALS Patients

News

A natural compound found in certain fruits and vegetables, called resveratrol, may help boost the ability of mesenchymal stem cells taken from amyotrophic lateral sclerosis (ALS) patients to transform into ... Read more

November 29, 2018November 29, 2018

Cytokinetics Completes Enrollment for Phase 2 Trial Evaluating Reldesemtiv for ALS

News

Cytokinetics has completed patient enrollment in its Phase 2 trial to evaluate the safety and potential of reldesemtiv to improve muscle function in patients with amyotrophic lateral sclerosis (ALS), ... Read more

November 21, 2018November 21, 2018

C9ORF72 Mutation Linked to High Risk of Melanoma in ALS and FTLD Patients in Study

News

Amyotrophic lateral sclerosis (ALS) or frontotemporal lobar degeneration (FTLD) patients with the C9ORF72 mutation are at an unusually high risk of malignant skin cancer and should be monitored for it, a ... Read more

November 19, 2018November 19, 2018

Higher Metabolic Rate May Contribute to ALS Development, Population-based Study Suggests

News

Health conditions that may lead to a faster metabolism, or higher metabolic rate, may contribute to the development of amyotrophic lateral sclerosis (ALS), a large-scale, population-based study suggests. The ... Read more

November 13, 2018November 13, 2018

Spinal Fluid and Blood Proteins May Diagnose and Predict Outcomes in ALS, Study Finds

News

Specific proteins analyzed in cerebral spinal fluid and blood samples may help to diagnose amyotrophic lateral sclerosis (ALS) and predict patient outcomes, researchers report. Cerebral spinal fluid (CFS) protein ... Read more

November 8, 2018November 8, 2018

SARM1 Inhibition Has Potential to Prevent Neurodegeneration in ALS, Other Diseases, Preclinical Results Suggest

News

Inhibition of the SARM1 gene can prevent the degeneration of nerve cells in the central, ocular, and peripheral nervous system in mice, results from preclinical studies show. These findings provide ... Read more

November 6, 2018November 6, 2018

Denali and Sanofi Partner to Advance Small Molecules That Might Treat ALS, Other Diseases

News

Denali Therapeutics and Sanofi have joined efforts to develop small molecule inhibitors of the RIPK1 enzyme, a new class of potential therapeutic agents for a range of neurological and ... Read more

October 16, 2018October 16, 2018

SOD1 Variants Can Have Different Effects on Nerve Cell Populations, Study in Worms Reveals

News

SOD1 gene mutations can contribute differently to the degenerative process of nerve cells involved in the progression of amyotrophic lateral sclerosis (ALS), newly developed worm models of the disease ... Read more

Posts by: Alice Melão

Alice Melão

ALS Patients’ Sexuality, Intimacy Issues Should Be Addressed by Healthcare Pros, Study Suggests

Biogen Acquires Full Rights to Develop, Market BIIB067 as Potential Treatment for ALS

Fruit Compound Called Resveratrol May Strengthen Abilities of Stems Cells of ALS Patients

Cytokinetics Completes Enrollment for Phase 2 Trial Evaluating Reldesemtiv for ALS

C9ORF72 Mutation Linked to High Risk of Melanoma in ALS and FTLD Patients in Study

Higher Metabolic Rate May Contribute to ALS Development, Population-based Study Suggests

Spinal Fluid and Blood Proteins May Diagnose and Predict Outcomes in ALS, Study Finds

SARM1 Inhibition Has Potential to Prevent Neurodegeneration in ALS, Other Diseases, Preclinical Results Suggest

Denali and Sanofi Partner to Advance Small Molecules That Might Treat ALS, Other Diseases

SOD1 Variants Can Have Different Effects on Nerve Cell Populations, Study in Worms Reveals

Pin It on Pinterest